Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan L Schultz

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Huntington'S Disease|May 31, 2018
Human Immunodeficiency Virus Infection in Huntington's Disease is Associated with an Earlier Age of Symptom OnsetJordan L Schultz, Peg C Nopoulos, Pedro Gonzalez-Alegre
Brain Sciences|August 23, 2020
The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's DiseaseJordan L Schultz, Amelia D Moser, Peg C Nopoulos
Journal of Huntington'S Disease|October 11, 2021
Quantifying the Onset of Unintended Weight Loss in Huntington's Disease: A Retrospective Analysis of Enroll-HDAmy C Ogilvie, Peg C Nopoulos, Jordan L Schultz
Muscle & Nerve|January 11, 2021
Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open-Access ALS Clinic Trials databaseElizabeth M Bald, Christopher S Nance, Jordan L Schultz
Parkinsonism & Related Disorders|August 27, 2021
Sleep disturbances by disease type and stage in Huntington's diseaseAmy C Ogilvie, Peg C Nopoulos, Jordan L Schultz
Journal of Huntington'S Disease|September 14, 2020
The Neurodevelopmental Hypothesis of Huntington's DiseaseEllen van der Plas, Jordan L Schultz, Peg C Nopoulos
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Differentiating Hyperkinetic and Hypokinetic Motor Features in the Progression of Huntington's DiseaseNabil Halabi, Annie Killoran, Peg C Nopoulos, et al.
Movement Disorders Clinical Practice|March 7, 2019
Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll-HD DatabaseJordan L Schultz, John A Kamholz, Peg C Nopoulos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2018
Statin use and delayed onset of Huntington's diseaseJordan L Schultz, Peg C Nopoulos, Annie Killoran, et al.
Journal of Psychosomatic Research|September 5, 2022
The effects of antidepressants on depressive symptoms in manifest Huntington's diseaseAmy C Ogilvie, Ryan M Carnahan, Elizabeth A Chrischilles, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Huntington'S Disease|May 31, 2018
Human Immunodeficiency Virus Infection in Huntington's Disease is Associated with an Earlier Age of Symptom OnsetJordan L Schultz, Peg C Nopoulos, Pedro Gonzalez-Alegre
Brain Sciences|August 23, 2020
The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's DiseaseJordan L Schultz, Amelia D Moser, Peg C Nopoulos
Journal of Huntington'S Disease|October 11, 2021
Quantifying the Onset of Unintended Weight Loss in Huntington's Disease: A Retrospective Analysis of Enroll-HDAmy C Ogilvie, Peg C Nopoulos, Jordan L Schultz
Muscle & Nerve|January 11, 2021
Melatonin may slow disease progression in amyotrophic lateral sclerosis: Findings from the Pooled Resource Open-Access ALS Clinic Trials databaseElizabeth M Bald, Christopher S Nance, Jordan L Schultz
Parkinsonism & Related Disorders|August 27, 2021
Sleep disturbances by disease type and stage in Huntington's diseaseAmy C Ogilvie, Peg C Nopoulos, Jordan L Schultz
Journal of Huntington'S Disease|September 14, 2020
The Neurodevelopmental Hypothesis of Huntington's DiseaseEllen van der Plas, Jordan L Schultz, Peg C Nopoulos
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Differentiating Hyperkinetic and Hypokinetic Motor Features in the Progression of Huntington's DiseaseNabil Halabi, Annie Killoran, Peg C Nopoulos, et al.
Movement Disorders Clinical Practice|March 7, 2019
Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll-HD DatabaseJordan L Schultz, John A Kamholz, Peg C Nopoulos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2018
Statin use and delayed onset of Huntington's diseaseJordan L Schultz, Peg C Nopoulos, Annie Killoran, et al.
Journal of Psychosomatic Research|September 5, 2022
The effects of antidepressants on depressive symptoms in manifest Huntington's diseaseAmy C Ogilvie, Ryan M Carnahan, Elizabeth A Chrischilles, et al.
Pageof 6